Inspra Helps, Natrecor Useless for Heart Patients
By wchung | 07 Jun, 2026
There’s good news for millions of people with mild or moderate heart failure. Studies show that the Pfizer drug Inspra and an implanted device from Medtronic can boost survival and cut down on trips to the hospital.
However, another drug that has been used for nearly a decade, Johnson & Johnson’s Natrecor (NAY’-treh-kor), did little to help people with severe heart failure in a study aimed at resolving safety concerns. Doctors say the drug seems safe but does not markedly help shortness of breath or save lives.
The studies were presented Sunday at an American Heart Association conference in Chicago.
MARILYNN MARCHIONE, AP Medical Writer CHICAGO
Recent Articles
- Your Answers to These 7 Questions Will Reveal Whether You're Sane or a Closet Lunatic
- US Oil Companies Profit from Strait of Hormuz Closure Says Russian Oil CEO
- Trump Faces New Republican Resistance in Congress as Midterms Approach
- SpaceX IPO Already Two Times Oversubscribed
- SpaceX Signs Google As AI Compute Client After Landing Anthropic
- $1 Trillion in Stock Market Valuation Erased by AI Chip Selloff
- Anthropic Urges Industry Pause As AI Nears Recursive Self-Development
- Trump's South Lawn UFC Birthday Bash to Mix Politics with Punches
- Trump Policies Targeting 39 Nationalities of Immigrants Invalidated
- One Man Holds Back the World's Progress toward Green Energy Sufficiency and Prosperity